Literature DB >> 1342961

In situ polymerase chain reaction detection of viral DNA, single-copy genes, and gene rearrangements in cell suspensions and cytospins.

P Komminoth1, A A Long, R Ray, H J Wolfe.   

Abstract

The study of low-copy viral or genomic DNA sequences by in situ hybridization (ISH) is often limited by sensitivity. Using the polymerase chain reaction (PCR) for the amplification of target DNA sequences in fixed cells [in situ PCR] (ISPCR) before ISH, we have been able to greatly improve the sensitivity of ISH. Viral DNA present in low copy number, single-copy genes, as well as immunoglobulin gene rearrangements (VH3 family genes), were successfully amplified in cells in suspension or on glass slides (cytospins). Single primer pairs were used in the in situ amplification step and 35S- or digoxigenin-11-dUTP-labeled region specific oligonucleotide probes were used for detection of amplificants by ISH. Artifacts, presumably resulting from leakage of in situ amplificants out of cells, may be a significant problem in selected instances. By optimal fixation and permeabilization of cells, limiting PCR cycle number, amplification of long DNA sequences, and/or incorporation of biotinylated dNTPs to produce bulkier amplificants together with washing of cells after ISPCR, diffusion artifacts were significantly reduced. Probe hybridization to single-stranded long PCR fragments or messenger RNA were excluded as a source for false-positive ISPCR results. The techniques reported dramatically increase the sensitivity of ISH in the detection of low-copy viral infection as well as in the study of gene rearrangements, and provide unique opportunities to study chromosomal translocations and point mutations at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1342961

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  15 in total

1.  Quantitative analysis of latent human cytomegalovirus.

Authors:  B Slobedman; E S Mocarski
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 2.  In cell amplification.

Authors:  V Uhlmann; I Silva; K Luttich; S Picton; J J O'Leary
Journal:  Mol Pathol       Date:  1998-06

3.  Epizootic hemorrhagic disease: analysis of tissues by amplification and in situ hybridization reveals widespread orbivirus infection at low copy numbers.

Authors:  S J Brodie; K D Bardsley; K Diem; J O Mecham; S E Norelius; W C Wilson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Immersion-histo polymerase chain reaction: a practical tool for visualization of single-copy genes in tissue sections.

Authors:  L Pan; T C Diss; H Peng; P G Isaacson
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

5.  Fluorescence in situ hybridization with cosmid clones for the detection of human cytomegalovirus DNA in peripheral blood leukocytes.

Authors:  H Hackstein; G Jahn; H Kirchner; G Bein
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

6.  In situ polymerase chain reaction: toy or tool?

Authors:  H Höfler
Journal:  Histochemistry       Date:  1993-02

7.  PCR in situ: aspects which reduce amplification and generate false-positive results.

Authors:  I A Teo; S Shaunak
Journal:  Histochem J       Date:  1995-09

8.  Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections. Detection of viral DNA, gene rearrangements and chromosomal translocations.

Authors:  A A Long; P Komminoth; E Lee; H J Wolfe
Journal:  Histochemistry       Date:  1993-02

9.  Questioning in situ PCR. Detection of epidermal growth factor receptor mRNA in tissue sections from biopsy specimens using in situ polymerase chain reaction.

Authors:  P Komminoth; A A Long
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

10.  Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization.

Authors:  A N Dueland; T Ranneberg-Nilsen; M Degré
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.